Beryl Drugs has informed that at its 19th meeting of the Board of the Directors of the company held on Tuesday, the 4th day of September, 2018 at 10.00 A.M. at the Registered office 133, Kanchan Bagh, Indore- 452001 (M.P) has considered and approved the Directors Report for the financial year ended on 31st March, 2018; considered and approved Book Closure Notice and fixed the cut -off date for entitlement of Voting Rights of Member for remote E-Voting; considered and approved 25th Annual General Meeting Notice and directed to dispatch the Notice to the Shareholders; and Authorized Directors of the Company to authenticate and file forms under Companies Act, 2013 on behalf of the Company.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: